https://prabadinews.com/
  • October 7, 2026
  • Last Update July 17, 2026 9:28 pm
  • United States of America

Insulin Efsitora Alfa Demonstrates A1C Reduction in Various Clinical Trials

Insulin Efsitora Alfa Demonstrates A1C Reduction in Various Clinical Trials

Once-weekly efsitora alfa shows promising hemoglobin A1C reduction in type 2 diabetes (T2D), simplifying insulin therapy and reducing injection frequency significantly.

administrator

Related Articles